blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3283630

EP3283630 - OLIGONUCLEOTIDE FRAGMENT, AND METHOD AS WELL AS APPLICATION OF SELECTIVE AMPLIFICTION OF VARIANT OF TARGET NUCLEIC ACID SEQUENCE USING THE SAME [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  31.05.2024
Database last updated on 03.10.2024
FormerThe patent has been granted
Status updated on  23.06.2023
FormerGrant of patent is intended
Status updated on  15.02.2023
FormerExamination is in progress
Status updated on  23.10.2020
FormerRequest for examination was made
Status updated on  19.01.2018
FormerThe international publication has been made
Status updated on  20.01.2017
Most recent event   Tooltip02.08.2024Lapse of the patent in a contracting state
New state(s): SI		published on 04.09.2024  [2024/36]
Applicant(s)For all designated states
Nuhigh Biotechnologies Co., Ltd
Suite 301 C8 218 Xinghu Road
Suzhou Industrial Park
Suzhou, Jiangsu 215123 / CN
[2018/08]
Inventor(s)01 / BI, Wanli
Suite 301 C8
218 Xinghu St.
Suzhou Industrial Park
Suzhou Jiangsu 215123 / CN
02 / WANG, Zhifeng
Suite 301 C8
218 Xinghu St.
Suzhou Industrial Park
Suzhou Jiangsu 215123 / CN
03 / XU, Xin
Suite 301 C8
218 Xinghu St.
Suzhou Industrial Park
Suzhou Jiangsu 215123 / CN
 [2018/08]
Representative(s)HGF
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
[2023/30]
Former [2018/08]HGF Limited
Delta House
50 West Nile Street
Glasgow G1 2NP / GB
Application number, filing date15888914.718.06.2015
[2018/08]
WO2015CN81818
Priority number, dateCN20151017795215.04.2015         Original published format: CN201510177952
[2018/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016165210
Date:20.10.2016
Language:EN
[2016/42]
Type: A1 Application with search report 
No.:EP3283630
Date:21.02.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 20.10.2016 takes the place of the publication of the European patent application.
[2018/08]
Type: B1 Patent specification 
No.:EP3283630
Date:26.07.2023
Language:EN
[2023/30]
Search report(s)International search report - published on:CN20.10.2016
(Supplementary) European search report - dispatched on:EP17.10.2018
ClassificationIPC:C12N15/11, C12N15/10, C12Q1/68, C12Q1/6858, C12Q1/6853
[2018/46]
CPC:
C12Q1/6858 (EP,US); C12Q1/6853 (EP,US)
C-Set:
C12Q1/6853, C12Q2525/117, C12Q2525/125, C12Q2525/301 (EP,US);
C12Q1/6858, C12Q2525/107, C12Q2525/125, C12Q2525/301 (US,EP);
C12Q1/6858, C12Q2525/113, C12Q2525/125, C12Q2525/301 (US,EP);
C12Q1/6858, C12Q2525/117, C12Q2525/125, C12Q2525/301 (US,EP);
C12Q1/6858, C12Q2525/186, C12Q2525/301 (EP,US)
(-)
Former IPC [2018/08]C12N15/11, C12N15/10, C12Q1/68
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/08]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:OLIGONUKLEOTIDFRAGMENT UND VERFAHREN SOWIE ANWENDUNG VON SELEKTIVER AMPLIFIKATION VON VARIANTEN EINER ZIELNUKLEINSÄURESEQUENZ DAMIT[2018/08]
English:OLIGONUCLEOTIDE FRAGMENT, AND METHOD AS WELL AS APPLICATION OF SELECTIVE AMPLIFICTION OF VARIANT OF TARGET NUCLEIC ACID SEQUENCE USING THE SAME[2018/08]
French:FRAGMENT OLIGONUCLÉOTIDIQUE ET PROCÉDÉ AINSI QU'APPLICATION D'AMPLIFICATION SÉLECTIVE D'UN VARIANT DE SÉQUENCE D'ACIDE NUCLÉIQUE CIBLE L'UTILISANT[2018/08]
Entry into regional phase19.01.2017National basic fee paid 
19.01.2017Search fee paid 
19.01.2017Designation fee(s) paid 
19.01.2017Examination fee paid 
Examination procedure23.01.2017Examination requested  [2018/08]
23.01.2017Date on which the examining division has become responsible
15.04.2019Amendment by applicant (claims and/or description)
22.10.2020Despatch of a communication from the examining division (Time limit: M04)
12.02.2021Reply to a communication from the examining division
16.02.2023Communication of intention to grant the patent
06.06.2023Fee for grant paid
06.06.2023Fee for publishing/printing paid
06.06.2023Receipt of the translation of the claim(s)
Opposition(s)29.04.2024No opposition filed within time limit [2024/27]
Fees paidRenewal fee
29.06.2017Renewal fee patent year 03
26.06.2018Renewal fee patent year 04
25.06.2019Renewal fee patent year 05
25.06.2020Renewal fee patent year 06
29.06.2021Renewal fee patent year 07
22.06.2022Renewal fee patent year 08
15.06.2023Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT26.07.2023
CZ26.07.2023
DK26.07.2023
EE26.07.2023
ES26.07.2023
FI26.07.2023
HR26.07.2023
IT26.07.2023
LT26.07.2023
LV26.07.2023
NL26.07.2023
PL26.07.2023
RO26.07.2023
RS26.07.2023
SE26.07.2023
SI26.07.2023
SK26.07.2023
SM26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
[2024/36]
Former [2024/26]AT26.07.2023
CZ26.07.2023
DK26.07.2023
EE26.07.2023
ES26.07.2023
FI26.07.2023
HR26.07.2023
IT26.07.2023
LT26.07.2023
LV26.07.2023
NL26.07.2023
PL26.07.2023
RO26.07.2023
RS26.07.2023
SE26.07.2023
SK26.07.2023
SM26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/23]AT26.07.2023
CZ26.07.2023
DK26.07.2023
EE26.07.2023
ES26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
NL26.07.2023
PL26.07.2023
RO26.07.2023
RS26.07.2023
SE26.07.2023
SK26.07.2023
SM26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/22]AT26.07.2023
CZ26.07.2023
DK26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
NL26.07.2023
PL26.07.2023
RO26.07.2023
RS26.07.2023
SE26.07.2023
SM26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/20]AT26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
NL26.07.2023
PL26.07.2023
RS26.07.2023
SE26.07.2023
SM26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/10]AT26.07.2023
FI26.07.2023
HR26.07.2023
LT26.07.2023
LV26.07.2023
NL26.07.2023
PL26.07.2023
RS26.07.2023
SE26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
PT27.11.2023
Former [2024/09]AT26.07.2023
FI26.07.2023
LT26.07.2023
NL26.07.2023
SE26.07.2023
NO26.10.2023
GR27.10.2023
IS26.11.2023
Former [2024/08]LT26.07.2023
NL26.07.2023
NO26.10.2023
GR27.10.2023
Former [2024/05]NL26.07.2023
Documents cited:Search[Y]EP0963443  (GENETRACE SYSTEMS INC [US]) [Y] 1-3 * paragraphs [0019] , [0021] - [0022] *;
 [Y]US2003073101  (OLSON JEFFREY [US], et al) [Y] 1-11 * figures 16-18,26-31 * * paragraphs [0118] - [0120] - [0128] - [0130] - [0235] - [0285] - [0286] - [0290] * * example 1 *;
 [Y]US2007264653  (BERLIN KURT [DE], et al) [Y] 1-11 * paragraphs [0176] , [ 191] - [0193] - [0238] , [ 425] - [0428] * * claims 1-19,22-24 *;
 [Y]WO2013123220  (UNIV CORNELL [US], et al) [Y] 1-11 * paragraphs [0020] , [0026] - [0028] - [0037] , [0059] , [0062] , [0070] , [0089] - [0091] * * figures 6,8 *;
 [Y]  - RAND KEITH N ET AL, "Headloop suppression PCR and its application to selective amplification of methylated DNA sequences", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, GB, (20050101), vol. 33, no. 14, doi:10.1093/NAR/GNI120, ISSN 1362-4962, pages e127 - 1, XP002515951 [Y] 1-11 * the whole document *

DOI:   http://dx.doi.org/10.1093/nar/gni120
 [A]  - SOLINAS A ET AL, "Duplex Scorpion primers in SNP analysis and FRET applications", NUCLEIC ACIDS RESEARCH, INFORMATION RETRIEVAL LTD, (20011015), vol. 29, no. 20, doi:10.1093/NAR/29.20.E96, ISSN 0305-1048, page E96, XP002318909 [A] 1-11 * the whole document *

DOI:   http://dx.doi.org/10.1093/nar/29.20.e96
International search[A]CN1580277  (FUWEI BIOLOG SCIENCE TECHNOLOG [CN]) [A] 1-11 * see claim 1 *;
 [A]WO2011100057  (SPIER EUGENE [US]) [A] 1-11* see claim 1 and figure 10 *
by applicantUS4469863
 US4912199
 US5034506
 US5137806
 US5210015
 US5216141
 US5235033
 US5273991
 US5338671
 US5386023
 US5411876
 US5538848
 US5602240
 US5637684
 US5637621
 US5639611
 US5644048
 WO9728123
 US5677152
 US5698674
 US5753629
 WO9821202
 US5773528
 US5840867
 US5877280
 US5990303
 EP0963443
 WO0174898
 US6326145
 WO0200650
 US2003073101
 WO03059881
 US2007264653
 US7408051
 WO2013123220
    - HENRIK et al., Nucleic Acid Research, (19930000), vol. 21, pages 5332 - 5336
    - LUO et al., Nucleic Acid Research, (20060000), vol. 34, no. 2, page e12
    - VOGELSTEIN BKINZLER KW, "Digital PCR", Proc Natl Acad Sci USA, (19990000), vol. 96, doi:10.1073/pnas.96.16.9236, pages 9236 - 41, XP002185144

DOI:   http://dx.doi.org/10.1073/pnas.96.16.9236
    - BIELAS JHLOEB LA, "Quantification of random genomic mutations", Nat Methods, (20050000), vol. 2, pages 285 - 90
    - LI JWANG LMAMON HKULKE MHBERBECO RMAKRIGIORGOS GM, "Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing", Nat Med, (20080000), vol. 14, pages 579 - 84
    - GASTER, J.MARX, A, Chem. Eur.J., (20050000), vol. 11, pages 1861 - 1870
    - SEELA et al., Helv.Chim. Acta, (19990000), vol. 82, page 1640
    - BEAUCAGE et al., Tetrahedron, (19930000), vol. 49, no. 10, page 1925
    - MAG et al., Nucleic Acids Res., (19910000), vol. 19, page 1437
    - BRIU et al., J. Am. Chem. Soc., (19890000), vol. 111, page 2321
    - EGHOLM, J. Am. Chem. Soc., (19920000), vol. 114, page 1895
    - DENPCY et al., Proc. Natl. Acad. Sci. USA, (19950000), vol. 92, page 6097
    - JENKINS et al., Chem. Soc. Rev., (19950000), pages 169 - 176
    - SONDHI et al., Curr. Med. Chem., (19970000), vol. 4, page 313
    - REDDY et al., Pharmacology & Therapeutics, (19990000), vol. 84, page 1
    - WEMMER, Biopolymers, (20010000), vol. 52, page 197
    - DERVAN, Bioorg. Med. Chem., (20010000), vol. 9, page 2215
    - Anti-Cancer Drug Design, (19900000), vol. 5, page 3
    - Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, page 7586
    - Biochemistry, (19930000), vol. 32, page 4237
    - Science, (19940000), vol. 266, page 647
    - Anti-Cancer Drug Design, (19950000), vol. 10, page 155
    - Bioorg Med. Chem., (20000000), vol. 8, page 985
    - Mol. Biol., (20000000), vol. 34, page 357
    - J Am. Chem. Soc., (19920000), vol. 114, no. 15, page 5911
    - Biochemistry, (19920000), vol. 31, page 8349
    - Bioconjugate Chem., (19940000), vol. 5, page 475
    - Biochem. Biophys. Res. Commun., (19960000), vol. 222, page 764
    - J Med.Chem., (20000000), vol. 43, page 3257
    - Tetrahedron, (20000000), vol. 56, page 5225
    - Molecular Pharmacology, (19980000), vol. 54, page 280
    - Bioorg Med. Chem. Lett., (19960000), vol. 6, no. 18, page 2169
    - J. Med. Chem., (20020000), vol. 45, page 805
    - Bioorg. Med. Chem. Lett., (20020000), vol. 12, page 2007
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.